Androstenedione
Vérifier sur isomerdesign
Androstenedione
Vérifier sur pubchem
4-ANDROSTENE-3-17-DI...
Vérifier sur drugmap
Data
InChI: InChI=1S/C19H26O2/c1-18-9-7-13(20)11-12(18)3-4-14-15-5-6-17(21)19(15,2)10-8-16(14)18/h11,14-16H,3-10H2,1-2H3
Synonymes: UNII-409J2J96VR,Δ4-dione,Androstendione,BDBM91713,Androtex,NSC-9563, ANDROSTENEDIONE, delta-4-Androstenedione,NCGC00259818-01,STK801871,ANDROSTENEDIONE [VANDF],NCGC00254238-01,(3aS,3bR,9aR,9bS,11aS)-9a,11a-dimethyl-1H,2H,3H,3aH,3bH,4H,5H,7H,8H,9H,9aH,9bH,10H,11H,11aH-cyclopenta[a]phenanthrene-1,7-dione,Tox21_110893,CAS-63-05-8,DSSTox_CID_4523,MLS002152886,409J2J96VR,Androstenedione (JAN),Testosterone EP Impurity A,Androstenedione (Androst-4-ene-3,17-dione) 1.0 mg/ml in Acetonitrile, Androst-4-ene-3,17-dione,D4-Androstene-3,17-dione,AKOS005622710,DELTA4-Androstene-3,17-dione,[4-14C]androst-4-ene-3,17-dione,Tox21_110893_1,SCHEMBL23272, 4-Androstene-3,17-dione,Tox21_202269,Androstenedione; 3,17-Dioxo-4-andostene,adione,(4)-Androsten-3,17-dione,SR-01000003096-4,delta4-androstenedione,delta-(sup4)-Androsten-3,17-dione, NSC 9563,NCGC00023902-07,delta-4-Androstene-3,17-dione,SR-01000075697-1,ANDROSTENEDIONE [MART.],CHEBI:16422, SKF 2170,LMST02020007,ANDROSTENEDIONE [MI],BIDD:PXR0101,AC-11042, delta-4-Androstene-3,17-dione,(8R,9S,10R,13S,14S)-10,13-dimethyl-7,8,9,10,11,12,13,14,15,16-decahydro-1H-cyclopenta[a]phenanthrene-3,17(2H,6H)-dione,c1015,(8R,10R,13S)-10,13-Dimethyl-1,6,7,8,9,10,11,12,13,14,15,16-dodecahydro-2H-cyclopenta[a]phenanthrene-3,17-dione,NCGC00023902-03, Androtex,androstenedione, Androstendione,Spectrum5_002059,8F5F4DCB-1164-4F2C-B4E3-3B74F684B189,androst-4-ene-3,17-dione (androstenedione),delta-4-Androstenedione,.DELTA.4-Androstene-3,17-dione,ANDROSTENEDIONE [HSDB],Q411064, EINECS 200-554-5,3,17-Dioxoandrost-4-ene,4-Androstene-3,17-dione, delta-(sup4)-Androsten-3,17-dione,4-Androsten-3,17-dione, 1963/5/8,NCGC00023902-05, Androstenedione [JAN],Delta(4)-androsten-3,17-dione,A0845,NCGC00023902-08,DB01536,HSDB 7335,SKF 2170,Androstenedione (Androst-4-ene-3,17-dione), 4-Androstenedione, d4-androstenedione,.delta.4-Androsten-3,17-dione,D00051,Tox21_300579,DSSTox_GSID_24523,DTXSID8024523,NCGC00023902-06,SR-01000075697,DSSTox_RID_77443,HMS2231F18,NSC9563,MLS000028510,NCGC00023902-04, MLS000028510,GTPL2860,TESTOSTERONE IMPURITY A [EP IMPURITY], androstenedione,CHEMBL274826,Androstenedione, delta(sup 4)-Androstene-3,17-dione,ZINC4428526,C00280,EU-0100114,Opera_ID_1694,W-104936,delta(sup 4)-Androstene-3,17-dione,63-05-8,delta-4-Androsten-3,17-dione,4-Androstenedione,4-ANDROSTENE-3-17-DIONE,4-ANDENDION,17-Ketotestosterone,VS-12118,A4, Fecundin, NSC9563,AC-33197,Androst-4-ene-3,17-dione,androst-4-en-3,17-dione,SMR000058281,.delta.-(sup4)-Androsten-3,17-dione,4-Androstene-3,17-dione, VETRANAL(TM), analytical standard,CCG-204209,Androstenedione [JAN],NSC 9563, UNII-409J2J96VR,A 9630,Delta(4)-androstene-3,17-dione,Androst-4-ene-3,17-dione; 17-Ketotestosterone; Androstenedione; 4-Androstene-3,17-dione; 4-Androstenedione,Epitope ID:135869,MLS000563086,EC 200-554-5, 3,17-Dioxoandrost-4-ene,SR-01000003096,NCGC00023902-09,BBL033517,EINECS 200-554-5,TESTOSTERONE RELATED COMPOUND A [USP-RS],ANDROSTENEDIONE [WHO-DD],Lopac0_000114,Androst-4-en-3,17-dione, 2, CHEBI:16422,(8R,9S,10R,13S,14S)-10,13-dimethyl-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthrene-3,17-dione,Fecundin,Estr-5-ene-3,17-diol,(3b,17b)-, 17-Ketotestosterone,[4-14C]-androstenedione, delta-4-Androsten-3,17-dione, 4-Androsten-3,17-dione, HSDB 7335,FT-0657562,WLN: L E5 B666 FV OV MUTJ A1 E1,117598-81-9,Androsten-3,17-dione
Estimated data
Solubility: -4.408 (log(S) in mol/L prediction using SolTranNet)
Blood Brain Barrier Permeability: No (prediction using frontiersin.org)
Addictivity Prediction: 69.4% (prediction based on www.mdpi.com)
